Akzo Nobel N.V. (AKZOY)

The Hindu Business Line  Apr 6  Comment 
The board of directors of Akzo Nobel India on Friday approved a proposal to buy back shares worth ₹235.20 crore. The company intends to buy back 11.20
The Hindu Business Line  Apr 5  Comment 
Shares of Akzo Nobel India will remain in focus on Friday, as its board of directors will meet to consider a proposal to buy back equity shares. If ap
The Economic Times  Apr 4  Comment 
The scrip was trading 5 per cent up at Rs 1891.15 at around 9.30 am (IST).
Wall Street Journal  Mar 27  Comment 
The sale of Akzo Nobel’s specialty-chemicals business for $12.6 billion will create a pure-play coatings company potentially attractive to U.S. paint giants Sherwin-Williams and PPG Industries.
Wall Street Journal  Mar 27  Comment 
A consortium led by Carlyle Group agreed to buy the specialty chemicals business of Akzo Nobel for $12.6 billion including debt, as the competition for bigger, riskier deals between cash-rich buyout firms heats up.


Related Articles


Based in the Netherlands, Akzo Nobel N.V.is a Global Fortune 500 chemicals company, producing a vast array of goods such as human and animal pharmaceuticals, paints, stains, hospital supplies, and other products. The company operates three business segments: Coatings, Chemicals, and Pharma. The Coatings segment makes decorative, industrial and protective coatings, as well as industrial finishes, car refinishes, and other industrial products. The Chemicals segment produces specialty, functional, and commodity chemicals. Its products include pulp and paper, surfactants, polymers and base chemicals, as well as high-quality salts. The Pharma segment is engaged in research, development, manufacturing, sales and services in strategic areas of human and animal healthcare. The Pharma business is named as Organon Biosciences (OBS). This segment comprises two units: Organon, which makes prescription medicines and produces complex active pharmaceutical ingredients and Intervet, which manufactures veterinary products.

Comparison to Competitors


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki